Cargando…
A Prognostic Risk Score Based on Hypoxia-, Immunity-, and Epithelialto-Mesenchymal Transition-Related Genes for the Prognosis and Immunotherapy Response of Lung Adenocarcinoma
Background: Lung adenocarcinoma (LUAD), the most common subtype of non-small cell lung cancer (NSCLC), is associated with poor prognosis. However, current stage-based clinical methods are insufficient for survival prediction and decision-making. This study aimed to establish a novel model for evalua...
Autores principales: | Ouyang, Wenhao, Jiang, Yupeng, Bu, Shiyi, Tang, Tiantian, Huang, Linjie, Chen, Ming, Tan, Yujie, Ou, Qiyun, Mao, Luhui, Mai, Yingjie, Yao, Herui, Yu, Yunfang, Lin, Xiaoling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819669/ https://www.ncbi.nlm.nih.gov/pubmed/35141229 http://dx.doi.org/10.3389/fcell.2021.758777 |
Ejemplares similares
-
Prognosis and Immunotherapy Response With a Novel Golgi Apparatus Signature-Based Formula in Lung Adenocarcinoma
por: Jiang, Yupeng, et al.
Publicado: (2022) -
A Comprehensive Analysis of Programmed Cell Death-Associated Genes for Tumor Microenvironment Evaluation Promotes Precise Immunotherapy in Patients with Lung Adenocarcinoma
por: Huang, Yunxi, et al.
Publicado: (2023) -
Peritoneal resident macrophages in tumor metastasis and immunotherapy
por: Zhang, Yu, et al.
Publicado: (2022) -
Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer
por: Yu, Yunfang, et al.
Publicado: (2020) -
Identification of a tumor immune-inflammation signature predicting prognosis and immune status in breast cancer
por: Liu, Yajing, et al.
Publicado: (2023)